Company Ticker News March 11, 2022AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q4 2021 Results - Earnings Call Transcript 0 0 Share
Company Ticker News March 10, 2022AcelRx Pharmaceuticals (ACRX) Reports Q4 Loss, Misses Revenue Estimates 0 0 Share
Company Ticker News March 10, 2022AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results 0 0 Share
Company Ticker News March 3, 2022AcelRx to Host Fourth Quarter and Full Year 2021 Financial Results Call and Webcast on March 10, 2022 0 0 Share
Press Release February 1, 2022AcelRx Pharmaceuticals Announces Publication of Clinical Data on the Use of Sufentanil Sublingual Tablet during Awake Plastic Surgery Procedures 0 0 Share
Press Release January 27, 2022AcelRx Pharmaceuticals Announces Publication of an Article Highlighting the Utility of the Sufentanil Sublingual Tablet in Pain Medicine Procedures 0 0 Share
Press Release January 12, 2022AcelRx Pharmaceuticals Announces Publication of an Editorial by an Internationally Recognized Leader in Opioid-Sparing Surgery Highlighting the Potential Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery 0 0 Share
Company Ticker News January 10, 2022AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics 0 0 Share
Company Ticker News January 1, 2022Top Penny Stocks To Buy According To Analysts & Targets Up To 615% 0 0 Share
